Axotrophin/MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein in vitro impairing microtubule binding

[1]  Michel Goedert,et al.  Tau pathology and neurodegeneration , 2013, The Lancet Neurology.

[2]  N. Nakamura,et al.  MARCH7 E3 ubiquitin ligase is highly expressed in developing spermatids of rats and its possible involvement in head and tail formation , 2013, Histochemistry and Cell Biology.

[3]  L. Buée,et al.  Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.

[4]  J. Götz,et al.  Animal models reveal role for tau phosphorylation in human disease. , 2010, Biochimica et biophysica acta.

[5]  Qiang Zhou,et al.  Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6 , 2009, Cell cycle.

[6]  D. Neary,et al.  TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing , 2009, Acta Neuropathologica.

[7]  Israel Hernandez,et al.  The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule , 2009, The Journal of Neuroscience.

[8]  Xiaoli Wang,et al.  Viral and cellular MARCH ubiquitin ligases and cancer. , 2008, Seminars in cancer biology.

[9]  P. Lehner,et al.  The Ubiquitin E3 Ligase MARCH7 is Differentially Regulated by the Deubiquitylating Enzymes USP7 and USP9X , 2008, Traffic.

[10]  Jae-Hyung Lee,et al.  RNABindR: a server for analyzing and predicting RNA-binding sites in proteins , 2007, Nucleic Acids Res..

[11]  G. Lyons,et al.  Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance. , 2006, International immunopharmacology.

[12]  E. Serfling,et al.  NFAT transcription factors in control of peripheral T cell tolerance , 2006, European journal of immunology.

[13]  T. Rapoport,et al.  E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Vasant G Honavar,et al.  Prediction of RNA binding sites in proteins from amino acid sequence. , 2006, RNA.

[15]  D. Butterfield,et al.  REVIEW: Pin1 in Alzheimer's disease , 2006, Journal of neurochemistry.

[16]  Stefani N. Thomas,et al.  Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation* , 2006, Journal of Biological Chemistry.

[17]  P. Fraser,et al.  Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein* , 2006, Journal of Biological Chemistry.

[18]  J. Gall,et al.  Subnuclear organelles: new insights into form and function. , 2006, Trends in cell biology.

[19]  S. Metcalfe.  Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[20]  D. Price,et al.  Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited , 2005, The Journal of Neuroscience.

[21]  G. Lyons,et al.  Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance , 2005, FEBS letters.

[22]  M. Bycroft,et al.  Solution Structure of the Kaposi's Sarcoma-associated Herpesvirus K3 N-terminal Domain Reveals a Novel E2-binding C4HC3-type RING Domain* , 2004, Journal of Biological Chemistry.

[23]  K. Nakayama,et al.  U‐box protein carboxyl terminus of Hsc70‐interacting protein (CHIP) mediates poly‐ubiquitylation preferentially on four‐repeat Tau and is involved in neurodegeneration of tauopathy , 2004, Journal of neurochemistry.

[24]  Søren Brunak,et al.  Analysis and prediction of leucine-rich nuclear export signals. , 2004, Protein engineering, design & selection : PEDS.

[25]  John Hardy,et al.  CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation , 2004 .

[26]  Steven P. Gygi,et al.  CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival* , 2004, Journal of Biological Chemistry.

[27]  K. Früh,et al.  Downregulation of Major Histocompatibility Complex Class I by Human Ubiquitin Ligases Related to Viral Immune Evasion Proteins , 2004, Journal of Virology.

[28]  A. Ciechanover,et al.  HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[30]  A. Delacourte,et al.  Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. , 2003, Biochimica et biophysica acta.

[31]  Akihiko Takashima,et al.  Chaperones increase association of tau protein with microtubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Goedert,et al.  Molecular cloning and functional characterization of chicken brain tau: isoforms with up to five tandem repeats. , 2002, Biochemistry.

[33]  Hirotaka Yoshida,et al.  Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.

[34]  L. Serpell,et al.  Proteasomal degradation of tau protein , 2002, Journal of neurochemistry.

[35]  D. Melton,et al.  "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.

[36]  T. Arendt,et al.  Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus , 2002, Acta Neuropathologica.

[37]  E. Hol,et al.  Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  R. Heumann,et al.  Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. I. Mitogen-activated protein kinase cascade , 2001, Neuroscience.

[39]  Y. Barde,et al.  Neurotrophins are required for nerve growth during development , 2001, Nature Neuroscience.

[40]  Y. Imai,et al.  Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.

[41]  J. Pasquini,et al.  Defective ubiquitination of cerebral proteins in Alzheimer's disease , 2000, Journal of neuroscience research.

[42]  Alexander Varshavsky,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[43]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[44]  P. Lehner,et al.  Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Markesbery,et al.  Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.

[46]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[47]  E. Mandelkow,et al.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Arendt,et al.  Modulation of APP processing and secretion by okadaic acid in primary guinea pig neurons , 2000, Journal of Neural Transmission.

[49]  P. Davies,et al.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.

[50]  E. Mandelkow,et al.  The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. , 1999, Molecular biology of the cell.

[51]  G. Drewes,et al.  MAPs, MARKs and microtubule dynamics. , 1998, Trends in biochemical sciences.

[52]  L. Hicke.  Ubiquitin‐dependent internalization and down‐regulation of plasma membrane proteins , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[54]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[55]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.

[56]  Khadija Iqbal,et al.  Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease , 1991, Brain Research.

[57]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.